Incannex – New Frontiers in Treatment

“Psychedelics, used responsibly and with proper caution, would be for psychiatry what the microscope is for biology and medicine, or the telescope is for astronomy.” – Stanislav Grof
Czech-born psychiatrist – founder and chief theoretician of transpersonal psychology

COVID has thrust health into the spotlight. There has been increased interest in health-related activities, from eating sustainable food to riding your Peloton bike. COVID has increased public awareness of the scale of mental health issues worldwide, and the scarcity of available treatments. Over 700m people globally are affected by mental illness, addiction or eating disorders. It is the current $70bn market for mental health which creates an opportunity for psychedelic based treatments. The psychedelics industry was valued at US$2bn in 2019 and is forecast to be US$7bn by 2027.